Company profile
a:head bio company profile
a:head provides a unique approach to drug development services. They develop new therapeutics for the treatment of brain disorders based on human cerebral organoids. Their drug discovery approach is based on human cerebral organoids, a revolutionary, paradigm-shifting new technology that allows the generation of mini-brains from human stem cells in vitro.
Business identity
- Website
- https://aheadbio.com/
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00011-00050 employees
- Revenue range
- $1K+
- Founded
- 2019-01-01
Headquarters
- Headquarters
- Vienna, Vienna, Austria
- Country code
- AT
- Continent
- Europe